drugset / Trial / NCT00661115

To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.

NCT00661115

Phase 3 Completed 173 enrolled Bayer
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the efficacy and safety of vardenafil in men with erectile dysfunction.

Timeline

Start
2003-05
Primary completion
2004-02
Completion
2004-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Vardenafil Small molecule 10 mg

Indications